Method and apparatus for delivering chronic and post-ischemia cardiac therapies

• US 20070043393A1
• Filed: 08/19/2005
• Published: 02/22/2007
• Est. Priority Date: 08/19/2005
• Status: Active Grant

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Zhang, Yi, Brockway, Marina, Shuros, Allan, Pastore, Joseph, Ricci, Carlos, Salo, Rodney
• Granted Patent: US 7,668,594 B2
• Time in Patent Office: Days
• US Class Current: 607/4
• CPC Class Codes: A61N 1/056 Transvascular endocardial electrode systems
• CPC Class Codes: A61N 1/36114 Cardiac control, e.g. by vagal stimulation stimulating the heart A61N1/362
• CPC Class Codes: A61N 1/3627 for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
• CPC Class Codes: A61N 1/36521 the parameter being derived from measurement of an electrical impedance
• CPC Class Codes: A61N 1/36557 controlled by chemical substances in blood
• CPC Class Codes: A61N 1/36585 controlled by two or more physical parameters

Abstract

An implantable cardiac rhythm management (CRM) device delivers a chronic therapy while detecting an ischemic state. When the ischemic state indicates the occurrence of an ischemic event, the implantable CRM device delivers a post-ischemia therapy. The post-ischemia therapy and the chronic therapy are adjusted using feedback control with the ischemic state and parameters indicative of the effectiveness of the post-ischemic therapy and the effectiveness of the chronic therapy as inputs.

Claims

1. A system for treating a heart with an ischemic region, the system comprising:

a sensing circuit to sense one or more physiological signals including one or more ischemia-indicating signals and one or more therapy-monitoring signals;

an ischemia detector, coupled to the sensing circuit, to detect an ischemic state indicative of an occurrence of an ischemic event from the one or more ischemia-indicating signals;

a therapy delivery device to deliver a post-ischemia therapy and a chronic therapy;

a therapy monitor, coupled to the sensing circuit, to produce one or more therapy-monitoring parameters from the one or more therapy-monitoring signals, the one or more therapy-monitoring parameters each indicative of effectiveness of at least one of the post-ischemia therapy and the chronic therapy; and

a controller coupled to the ischemia detector, the therapy delivery device, and the therapy monitor, the controller including;

a post-ischemia therapy controller adapted to initiate a delivery of the post-ischemia therapy and to adjust the delivery of the post-ischemia therapy based on the detected ischemic state and at least one post-ischemia therapy-monitoring parameter of the one or more therapy-monitoring parameters; and

a chronic therapy controller adapted to adjust a delivery of the chronic therapy based on the detected ischemic state and at least one chronic therapy-monitoring parameter of the one or more therapy-monitoring parameters.

2. The system of claim 1, further comprising an implantable housing configured to house the sensing circuit, the ischemia detector, the therapy delivery device, the therapy monitor, and the controller.

3. The system of claim 2, wherein the ischemic detector comprises an ischemia locator adapted to locate the ischemic region, and wherein the post-ischemia therapy controller is adapted to cause the post-ischemia therapy to be delivered to the located ischemic region.

4. The system of claim 3, further comprising a plurality of implantable leads coupled to the sensing circuit, the implantable leads each including a plurality of electrodes to sense a plurality of regional electrograms, and wherein the ischemia locator is adapted to locate the ischemic region using the plurality of regional electrograms.

5. The system of claim 3, further comprising a plurality of implantable leads coupled to the sensing circuit, the implantable leads each including a plurality of electrodes to sense a plurality of regional impedance signals, and wherein the ischemia locator is adapted to locate the ischemic region using the plurality of regional impedance signals.

6. The system of claim 3, further comprising a plurality of implantable leads and a plurality of strain sensors incorporated into the implantable leads, and wherein the ischemia locator is adapted to locate the ischemic region using signals sensed by the plurality of strain sensors.

7. The system of claim 3, further comprising a plurality of electrodes incorporated onto the implantable housing to sense a plurality of subcutaneous electrocardiogram (ECG) vectors, and wherein the ischemia locator is adapted to locate the ischemic region by analyzing the plurality of subcutaneous ECG vectors.

8. The system of claim 1, wherein the post-ischemia therapy controller is adapted to initiate the delivery of the post-ischemia therapy by adjusting one or more parameters of the chronic therapy.

9. The system of claim 1, wherein the therapy delivery device comprises a pacing output circuit adapted to deliver a chronic pacing therapy, and the chronic therapy controller comprises a chronic pacing controller adapted to control the delivery of the chronic pacing therapy by adjusting one or more pacing parameters of the chronic pacing therapy based on the detected ischemic state and the at least one chronic therapy-monitoring parameter.

10. The system of claim 9, wherein the therapy delivery device further comprises a neural stimulation circuit adapted to deliver a post-ischemia neural stimulation therapy, and the post-ischemia therapy controller comprises a neural stimulation controller adapted to initiate and control the post-ischemia neural stimulation therapy.

11. The system of claim 9, wherein the therapy delivery device further comprises a drug delivery device adapted to deliver a post-ischemia drug therapy, and the post-ischemia therapy controller comprises a drug delivery controller adapted to initiate and control the post-ischemia drug therapy.

12. The system of claim 9, wherein the therapy delivery device further comprises a biological therapy device adapted to deliver a post-ischemia biological therapy, and the post-ischemia therapy controller comprises a biological therapy controller adapted to initiate and control the post-ischemia biological therapy.

13. The system of claim 9, wherein the cardiac pacing circuit is further adapted to deliver a post-ischemia pacing therapy, and the post-ischemia therapy controller comprises a post-ischemia pacing controller adapted to control the delivery of the post-ischemia pacing therapy.

14. The system of claim 13, wherein the post-ischemia pacing controller is adapted to control the delivery of the post-ischemia pacing therapy by adjusting one or more pacing parameters of the chronic pacing therapy for a pre-excitation of the ischemic region.

15. A method for treating a heart with an ischemic region, the method comprising:

delivering a chronic therapy;

sensing one or more physiological signals;

detecting an ischemic state indicative of an occurrence of an ischemic event from one or more ischemia-indicating signals of the one or more physiological signals;

initiating a delivery of a post-ischemia therapy in response to the occurrence of the ischemic event as indicated by the detected ischemic state;

producing one or more therapy-monitoring parameters from one or more therapy-monitoring signals of the one or more physiological signals, the one or more therapy-monitoring parameters each indicative of effectiveness of at least one of the chronic therapy and the post-ischemia therapy; and

adjusting the delivery of the chronic therapy and the delivery of the post-ischemia therapy based on the detected ischemic state and the one or more therapy-monitoring parameters.

16. The method of claim 15, further comprising:

locating the ischemic region; and

delivering the post-ischemia therapy to the ischemic region.

17. The method of claim 16, wherein sensing the one or more physiologic signals comprises sensing one or more physiologic signals using a plurality of electrodes, and locating the ischemic region comprises identifying at least one electrode of the plurality of electrodes in or closest to the ischemic region.

18. The method of claim 15, wherein producing the one or more therapy-monitoring parameters comprises:

producing at least one chronic therapy-monitoring parameter from at least one chronic therapy-monitoring signal of the one or more therapy-monitoring signals, the at least one chronic therapy-monitoring parameter indicative of effectiveness of the chronic therapy; and

producing at least one post-ischemia therapy-monitoring parameter from at least one post-ischemia therapy-monitoring signal of the one or more therapy-monitoring signals, the at least one post-ischemia therapy-monitoring parameter indicative of effectiveness of the post-ischemia therapy,

and wherein adjusting the delivery of the chronic therapy and the delivery of the post-ischemia therapy comprises;

adjusting the delivery of the chronic therapy based on the detected ischemic state and the at least one chronic therapy-monitoring parameter; and

adjusting the delivery of the post-ischemia therapy based on the detected ischemic state and the at least one post-ischemia therapy-monitoring parameter.

19. The method of claim 15, wherein delivering the chronic therapy comprises delivering cardiac pacing pulses to a plurality of regions in the heart.

20. The method of claim 19, wherein initiating the delivery of the post-ischemia therapy comprises initiating a delivery of a neural stimulation therapy.

21. The method of claim 19, wherein initiating the delivery of the post-ischemia therapy comprises initiating a delivery of a drug therapy.

22. The method of claim 19, wherein initiating the delivery of the post-ischemia therapy comprises initiating a delivery of a biological therapy.

23. The method of claim 19, wherein initiating the delivery of the post-ischemia therapy comprises initiating the delivery of the post-ischemia therapy by adjusting one or more pacing parameters of the chronic therapy, and wherein the chronic therapy comprises delivering the cardiac pacing pulses in an atrial tracking mode.

24. The method of claim 23, wherein adjusting the one or more pacing parameters of the chronic therapy comprises shortening at least one atrioventricular delay associated with the ischemic region.

25. The method of claim 24, wherein adjusting the one or more pacing parameters comprises lowering a lower rate limit in response to the occurrence of the ischemic event.